Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering statin medications at the start of their cancer treatment had a 61% lower risk of dying from their cancer compared to similar patients who were not taking statins, according to a new study.
from Top Health News -- ScienceDaily https://ift.tt/KauRvsN
No comments:
Post a Comment